Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase

Archives of Iranian Medicine

Volumn 13, Issue 3, 2010, Pages 193-202

  Montazeri, Ghodrate ^a   Rahban, Maryam ^a   Mohamadnejad, Mehdi ^a   Zamani, Farhad ^b   Hooshyar, Afshin ^a   Fazlolahi, Atoosa ^a   Abedian, Shifteh ^a   Ghoujeghi, Farhad ^a   Estakhri, Arezoo ^a   Montazeri, Farhad ^a   Razjoyan, Hadi ^a   Mamarabadi, Mansoureh ^a   Alimohamadi, Meysam ^a   Tavangar, Seyed Mohamad ^c   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iran University   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alt; Grade; Hbv dna; Stage; Total score

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B(E) ANTIGEN; PROTHROMBIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER HISTOLOGY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VIRUS LOAD;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; DNA, VIRAL; FOLLOW-UP STUDIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77953062035     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995; 13: S47-S49.
2. Lee W. Hepatitis B virus infection. N Eng J Med. 1997; 337: 1733-1745.
3. Lok AS. Hepatitis B infection: pathogenesis and management. J Hepathol. 2000; 32 (1supp): 89-97.
4. Montazeri G. Current treatment of chronic hepatitis B. Arch Iran Med. 2006; 9: 1-10.
5. Merat SH, Malekzadeh R, Rezvan H, M Khatibian. Hepatitis B in Iran. Arch Iran Med. 2000; 3: 192-201.
6. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Se-roepidemiology of hepatitis B, delta and human immunodeficiency virus in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993; 96: 277-287.
7. Forouzendeh B, Rezvan H, Mirmajlassi SH. Seroep-idemiologic study of hepatitis B virus and its role in the pathogenesis of chronic liver disease and hepatocellular carcinoma in Iranian patients. J Med Counc IR Iran. 1992; 11: 241-249.
8. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985; 151: 599-603.
9. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute surface antigen-positive hepatitis in Greek adults. Gastroenterology. 1987; 92: 1844-1850.
10. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology. 2001; 120: 1828-1853.
11. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology. 2001; 34: 1225-1241.
12. Martinot-Peignoux M, Boyer N, Colombat M, Akre-mi R, Pham BN, Ollivier S, et al. Serum hepatitis B virus DNA level and liver histology in inactive HBs Ag carriers. J Hepatol. 2002; 36: 543-546.
13. Manesis EK, Papatheodoridis GV, Hadziyannis SJ. Serum HBV DNA level in inactive hepatitis B virus carriers. Gastroenterology. 2002; 122: 2092-2093.
14. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006; 295: 65-73.
15. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B virus load. Gasrtoenterology. 2006; 130: 678-686.
16. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology. 2002; 36: 1408-1415.
17. Liaw YF, Leung N, Guan R, Lau GK, Merican I, Mc-Caughan G, et al. Asian-Paciic consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int. 2005; 25: 472-489.
18. Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guideline for the management of HBV infection. Z Gastroenterol. 2007; 45: 1281-1328.
19. Lok AS, McMahon BJ. Chronic hepatitis B. Hepa-tology. 2007; 45: 507-539.
20. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006; 4: 936-962.
21. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology. 2008; 134: 1376-1384.
22. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007; 47:760-767.
23. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, Sabahi F, Adeli A, Noorinayer B, et al. Genotype characterization and analysis of hepatitis B virus isolates from Iranian patients. J Med Virol. 2005; 75: 227-234.
24. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005; 76: 318-326.
25. Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sa-deghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol. 2006; 28: 5211-5213.
26. Poustchi H, Mohammadkhani A, Bowden S, Mon-tazeri G, Ayres A, Revill P, et al. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat. 2008; 15: 753-760.
27. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1: 431-435.
28. Chien RN, Liaw YF, Atkins M. Pretherapy alanine transaminase as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Hepatology. 1999; 30: 770-774.
29. Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, et al. Predictor of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepa-tology. 2002; 36: 186-194.
30. 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet. 1988; 2: 298-302.
31. Lok AS, Wu PC, Lai CL, Lau JY, Leung EK, Wong LS, et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gas-troenterology. 1992; 102: 2091-2097.
32. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thong-sawat S, Cooksley G, et al. Peginterferon alfa-2a, la-mivudine, and the combination for HBeAg positive chronic hepatitis B. N Engl J Med. 2005; 352: 2682-2695.
33. + chronic hepatitis B treated with adefovir dipivoxil (ADV). J Hepatol. 2002; 37: 39.
34. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated deinitions of healthy ranges for serum alanine aminotransferase levels. Ann Inter Med. 2002; 137: 1-9.
35. Papatheodoridis GV, Manesis EK, Manolakopou-los S, Elefsiniotis IS, Goulis J, Giannousis J, et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decision in hepatitis B e antigen-negative chronic hepatitis B virus? Hepatology. 2008; 48: 1451-1459.
36. Tsang PS, Trinh H, Garcia RT, Phan JT, Ha NB, Nguyen H, et al. Signiicant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol. 2008; 6: 569-574.